Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,073 total articles
CVB Financial Corp. and Heritage Commerce Corp. announced shareholder approval for their proposed merger. The transaction, pending regulatory approvals, is expected to close in the second quarter of 2026. The merger aims to combine two strong California-based banking organizations to enhance service offerings and achieve operational synergies.
Rapid7, Inc. announces the granting of inducement awards totaling 467,945 RSUs and 525,769 PSUs to Kenzo Security employees and founders as part of its acquisition deal, aiming to retain key talent and achieve revenue goals tied to its AI-powered cybersecurity managed detection and response services.
Vivani Medical, a clinical-stage biopharmaceutical company, announced positive results from their first-in-human LIBERATE-1 study and preclinical data for their semaglutide implant (NPM-139), demonstrating sustained drug exposure and over 20% weight loss for one year. The company plans to initiate a Phase 1 clinical study in mid-2026 with anticipat…
AmpliTech Group reported a stellar fiscal year 2025 with revenue reaching $25.2 million, marking a 165% increase from the prior year, driven by strong demand for its 5G-related low noise amplifier and block products. The company strategically invested in expanding its 5G product lines and penetration into Tier 1 network operators despite gross marg…
Nanobiotix, a late-clinical stage biotechnology company specializing in nanoparticle-based cancer treatments and other diseases, announced it will report its financial results for Q4 and full year 2025 on March 31, 2026. The results will be followed by a conference call and webcast on April 1, 2026, where company executives will provide a business …
Stifel Financial Corp. reported operating data for February 2026 highlighting a 12% year-over-year increase in total client assets (excluding assets sold), 16% growth in fee-based client assets, and substantial treasury deposit growth driven by venture banking. The company completed the sale of Stifel Independent Advisors in early February 2026. De…
Acuity Inc., a leading industrial technology company listed on NYSE under the ticker AYI, declared a quarterly dividend of 20 cents per share payable on May 1, 2026 to shareholders of record as of April 17, 2026. The company continues to focus on growth through innovation in lighting and intelligent space technologies.
Middlesex Water Company announced the appointment of Tatyana Kaplan as its new Vice President and Chief Accounting Officer effective March 26, 2026. Kaplan brings extensive experience in regulated utility accounting from her previous roles at Veolia North America, Prudential Financial, and PricewaterhouseCoopers. The company also announced the tran…
Xos, Inc. reported its fourth quarter and full-year 2025 financial results, achieving its third consecutive quarter of positive operating and free cash flow. The company expanded its platform with first production powertrains delivered to Blue Bird school buses and advanced its energy storage technology with significant gigawatt-hour charging miles…
Rank One Computing Corporation (ROC) announced that its ROC Access Face1 biometric reader has won the 'Best in Biometrics' award at the 2026 Security Industry Association New Products and Solutions Awards at ISC West. The product's innovative design and integration of biometric verification, video analytics, and intelligent access demonstrate ROC's…
Vroom, Inc. announced its Q4 and full-year 2025 financial results highlighting a $129.3 million improvement in net loss compared to 2024 and strengthened liquidity with $48.7 million total available. The company emerged from Chapter 11 in January 2025 with fresh start accounting impacting comparability. Despite improvements, adjusted net loss remai…
CapsoVision, Inc. reported a 13% increase in Q4 2025 revenue and 15% growth for the full year compared to 2024, driven by increased sales of its CapsoCam Plus capsule endoscopy products. The company advanced its AI-assisted imaging technology with a 510(k) FDA submission, developed new CMOS sensors under an agreement with Canon, and raised $14 mill…
Beyond Air, Inc. announced that CEO Steve Lisi has resigned and Robert Goodman, the current Chief Commercial Officer, has been appointed as CEO effective immediately. The change aims to accelerate market adoption and scale commercial operations of their LungFit PH medical device. Mr. Goodman brings extensive leadership experience in healthcare and …
Rani Therapeutics announced its Q4 and full-year 2025 financial results along with significant corporate developments. The company secured a collaboration and licensing agreement with Chugai Pharmaceutical valued up to $1.085 billion, successfully completed a $60.3 million private placement, and initiated a Phase 1 clinical trial for RT-114, an ora…
Oxford Industries, owner of brands including Tommy Bahama and Lilly Pulitzer, reported a challenging fiscal 2025 with a 3% decrease in annual net sales to $1.48 billion and a GAAP loss per share of $1.86, impacted by noncash impairment charges and increased tariffs. Despite pressures, the company initiated fiscal 2026 guidance anticipating improved…
CEA Industries provides an update on ongoing efforts to renegotiate its Asset Management Agreement (AMA) with 10X Capital Asset Management LLC. The current Board of Directors seeks to amend the AMA with more favorable terms including reduced management fees, shorter contract term, and adjusted liquidated damages. However, 10X Capital has been uncoo…
TOMI Environmental Solutions, a NASDAQ-listed global company specializing in disinfection and decontamination technologies, announced it will release its fourth quarter 2025 financial results after market close on March 31, 2026, accompanied by a conference call. The company focuses on providing advanced environmental disinfection solutions utilizi…
Iridex Corporation reported Q4 2025 revenues of $14.7 million, up 16% year-over-year, and full-year 2025 revenues of $52.7 million, an 8% increase from 2024. The company achieved positive adjusted EBITDA for the first time recently, driven by growth in glaucoma and retina product sales and reduced operating expenses. Despite global challenges, incl…
Datacentrex, Inc., a digital infrastructure firm specializing in Scrypt-based proof-of-work compute assets, has announced a proposed public offering of its common stock and pre-funded warrants. The net proceeds from this offering are intended to support working capital and general corporate needs. The offering is subject to market conditions and re…
INNOVATE Corp. announced its Q4 and full-year 2025 results featuring a 12.5% revenue increase driven mainly by its Infrastructure segment. The company improved net loss compared to the prior year quarter, boosted backlog to $1.8 billion, and made strides in Life Sciences with FDA approval and a major China system commitment. Despite softness in Spe…
Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) announced the submission of its GraftAssureDx transplant rejection test for FDA regulatory review, marking a milestone after 12 years of development. The company reported Q4 2025 revenues of $1.1 million and a full year of $4.1 million, driven by lab services, while gearing up for commercial launch …
VirTra, Inc., a Nasdaq-listed provider of use-of-force and firearms training simulators, reported a 15% revenue decline to $22.4 million for 2025, impacted by an atypical federal funding disruption delaying customer procurement and deliveries. Despite revenue pressures, bookings increased to $26.7 million, and backlog grew to $25.6 million. The com…
Great Southern Bancorp, Inc. announced it will release preliminary earnings for the first quarter of 2026 on April 15 after market close. The company will also hold an investor conference call on April 16 to discuss results. The earnings release and call details will be available on the company’s website and through SEC filings.
Spero Therapeutics announced positive financial results for the fourth quarter and full year of 2025, highlighted by a net income turnaround and increased revenues driven by collaborations with GSK and Pfizer. In December 2025, Spero's licensing partner, GSK, resubmitted the New Drug Application for tebipenem HBr, an oral carbapenem antibiotic for …
LB Pharmaceuticals reported positive results from Phase 2 trials of LB-102 in schizophrenia, initiated pivotal Phase 3 and additional Phase 2 trials for bipolar depression and major depressive disorder, and announced a $100 million private placement. The company has a strong cash position of $295.2 million as of December 31, 2025, providing a runwa…
